Related references
Note: Only part of the references are listed.What is going on with my samples? A general approach to parallelism assessment and data interpretation for biomarker ligand-binding assays
Shawn Ciotti et al.
BIOANALYSIS (2013)
Bioanalysis of antibody-drug conjugates: American Association of Pharmaceutical Scientists Antibody-Drug Conjugate Working Group position paper
Boris Gorovits et al.
BIOANALYSIS (2013)
2013 White Paper on recent issues in bioanalysis: 'hybrid' - the best of LBA and LCMS
Lauren Stevenson et al.
BIOANALYSIS (2013)
The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation
Peter van Amsterdam et al.
BIOANALYSIS (2013)
Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix®, a CTLA-4-Fc fusion protein, in renal and liver transplant patients
Heather A. Myler et al.
BIOANALYSIS (2012)
2012 White Paper on Recent Issues in Bioanalysis and Alignment of Multiple Guidelines
Binodh DeSilva et al.
BIOANALYSIS (2012)
Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC)
Mark Boterman et al.
BIOANALYSIS (2012)
Bioanalytical Approaches to Quantify Total and Free Therapeutic Antibodies and Their Targets: Technical Challenges and PK/PD Applications Over the Course of Drug Development
Jean W. Lee et al.
AAPS JOURNAL (2011)
Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies
Marie-Anne Valentin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Biotherapeutic bioanalysis: a multi-indication case study review
Heather A. Myler et al.
BIOANALYSIS (2011)
Troubleshooting PEG-hGH detection supporting pharmacokinetic evaluation in growth hormone deficient patients
Heather A. Myler et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Fit-for-purpose method development and validation for successful biomarker measurement
JW Lee et al.
PHARMACEUTICAL RESEARCH (2006)
Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data
PG Gottschalk et al.
JOURNAL OF BIOPHARMACEUTICAL STATISTICS (2005)
Statistical correction for non-parallelism in a urinary enzyme immunoassay
KA O'Connor et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2004)
Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
B DeSilva et al.
PHARMACEUTICAL RESEARCH (2003)
Share Paper
